RE: 6 Posts 5 Ticked Up25 Apr 2025 15:30
Afternoon all.
Good points being made tbh. My 2Ps worth:
I’m looking at any RNSs through the prism of today’s politics and global economy. I think it’s very reassuring that RUA is primarily focused on making a profit. Becoming self sufficient and self contained is, I think, the right way to approach business at present. I’m guessing this mind set has influenced the Vascular products. The costs and time to market vs potential profit doesn’t make sense at present.
AurTex is the potential silver lining here. RUA has more and more data from its accelerated fatigue testing of the product. Though the original “interested party” didn’t pursue it, if it’s as unique as reported, plenty of other manufacturers will be taking a look. This isn’t restricted to health care.